United States Pharmaceuticals

Theravance Biopharma Inc (TBPH)

Track

Track

Theravance Biopharma Inc. experienced significant selling activity over the past ninety days, totaling over six million dollars. Key insiders, including Eli Samaha and Rhonda Farnum, executed multiple divestments. These transactions occurred despite a modest three percent stock price increase, following recent results financiers that missed earnings expectations by fifty percent.
Ticker: TBPH Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Theravance Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Samaha Eli Large shareholder
Transaction date
Sale
Price
126.72
Quantity 4,516 -9.9%
Value US$2,061,520
3.2
Samaha Eli Large shareholder
Transaction date
Sale
Price
274.91
Quantity 12,359 -48.0%
Value US$1,702,475
3.2
Samaha Eli Large shareholder
Transaction date
Sale
Price
374.00
Quantity 55,495 -6.6%
Value US$3,943,815
3.2
Samaha Eli Large shareholder
Transaction date
Sale
Price
17.13
Quantity 25,027 -0.3%
Value US$428,788
3.2
Samaha Eli Large shareholder
Transaction date
Sale
Price
17.23
Quantity 273,871 -2.9%
Value US$4,720,139
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
16.39
Quantity 6,657 -2.8%
Value US$109,079
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
16.38
Quantity 3,328 -1.4%
Value US$54,525
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
16.39
Quantity 3,329 -1.4%
Value US$54,563
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
16.39
Quantity 13,314
Value US$218,167
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
13.92
Quantity 7,766 -3.2%
Value US$108,073
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
14.00
Quantity 15,534 -6.1%
Value US$217,476
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
13.92
Quantity 7,767 -2.9%
Value US$108,088
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
13.96
Quantity 31,067
Value US$433,637
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
18.75
Quantity 15,534 -5.3%
Value US$291,252
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
18.75
Quantity 7,766 -2.6%
Value US$145,619
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
18.75
Quantity 7,767 -2.5%
Value US$145,630
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
18.75
Quantity 31,067
Value US$582,500
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Planned sale
Price
20.00
Quantity 15,501 -25.7%
Value US$310,020
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Planned sale
Price
20.00
Quantity 14,000 -18.9%
Value US$280,000
1.7
ERAN BROSHY Director Non-Executive Director
Transaction date
Proposed sale
Price
20.00
Quantity 29,501
Value US$590,020
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Planned sale
Price
18.50
Quantity 14,000 -23.3%
Value US$259,000
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Planned sale
Price
17.00
Quantity 15,500 -25.1%
Value US$263,500
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Planned sale
Price
18.50
Quantity 29,500 -32.3%
Value US$545,750
1.7
ERAN BROSHY Director Non-Executive Director
Transaction date
Proposed sale
Price
17.98
Quantity 45,000
Value US$809,250
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
11.39
Quantity 4,000 -1.2%
Value US$45,552
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
11.39
Quantity 5,318 -1.6%
Value US$60,548
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
11.39
Quantity 682 -0.2%
Value US$7,770
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
11.39
Quantity 10,000
Value US$113,869
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
11.00
Quantity 24,000 -6.6%
Value US$264,000
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
11.00
Quantity 24,000
Value US$264,000
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
9.00
Quantity 4,000 -1.1%
Value US$36,000
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
9.00
Quantity 4,000 -1.3%
Value US$36,000
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
9.00
Quantity 4,000
Value US$36,000
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
9.00
Quantity 4,000 -1.2%
Value US$36,000
3.2
Samaha Eli Large shareholder
Transaction date
Purchase
Price
7.80
Quantity 999,800 +11.7%
Value US$7,798,440
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
9.00
Quantity 4,000 -1.2%
Value US$36,000
3.2
Samaha Eli Large shareholder
Transaction date
Purchase
Price
8.75
Quantity 499,324 +6.2%
Value US$4,369,085
3.2
Samaha Eli Large shareholder
Transaction date
Purchase
Price
8.75
Quantity 999,800 +14.3%
Value US$8,748,250
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
8.71
Quantity 1,254 -0.4%
Value US$10,922
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
10.29
Quantity 1,378 -0.4%
Value US$14,180
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
10.22
Quantity 2,482 -0.7%
Value US$25,366
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
10.22
Quantity 2,482
Value US$25,366
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
9.03
Quantity 2,482 -0.7%
Value US$22,412
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
9.03
Quantity 2,482
Value US$22,412
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
9.89
Quantity 2,482 -0.7%
Value US$24,547
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
9.89
Quantity 2,482
Value US$24,547
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
9.47
Quantity 1,807 -0.5%
Value US$17,112
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
9.99
Quantity 2,322 -0.7%
Value US$23,197
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
9.99
Quantity 2,322
Value US$23,197
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
9.84
Quantity 2,322 -0.7%
Value US$22,848
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
9.84
Quantity 2,322
Value US$22,848
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
10.69
Quantity 2,322 -0.7%
Value US$24,822
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
10.69
Quantity 2,322
Value US$24,822
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
11.13
Quantity 1,790 -0.5%
Value US$19,923
2.6
RHONDA FARNUM Officer Officer
Transaction date
Proposed sale
Price
11.13
Quantity 1,790
Value US$19,923
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
11.26
Quantity 2,322 -0.6%
Value US$26,146
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
11.26
Quantity 2,322
Value US$26,146
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
11.88
Quantity 2,323 -0.6%
Value US$27,597
2.1
RICHARD A GRAHAM Officer Officer
Transaction date
Proposed sale
Price
11.88
Quantity 2,323
Value US$27,597
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
10.32
Quantity 2,323 -0.6%
Value US$23,973
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Sale
Price
10.20
Quantity 4,000 -1.1%
Value US$40,800
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Planned sale
Price
10.05
Quantity 2,323 -0.6%
Value US$23,346
3.5
Winningham Rick E CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Sale
Price
11.19
Quantity 50,000 -3.6%
Value US$559,500
2.1
GRAHAM RICHARD A SVP, RESEARCH & DEVELOPMENT Officer
Transaction date
Sale
Price
10.73
Quantity 2,084 -0.7%
Value US$22,361
2.8
Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
11.02
Quantity 65,000 -13.7%
Value US$716,242
2.1
GRAHAM RICHARD A SVP, DEVELOPMENT Officer
Transaction date
Sale
Price
9.71
Quantity 4,906 -1.3%
Value US$47,640
2.1
GRAHAM RICHARD A SVP, DEVELOPMENT Officer
Transaction date
Sale
Price
8.79
Quantity 15,086 -3.9%
Value US$132,606
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
8.93
Quantity 1,081 -0.3%
Value US$9,653
2.6
Farnum Rhonda SVP, COMM & MEDICAL AFFAIRS Officer
Transaction date
Planned sale
Price
10.16
Quantity 2,356 -0.7%
Value US$23,947
2.9
WORBOYS PHILIP D SVP, Research & Transl Science Officer
Transaction date
Sale
Price
20.00
Quantity 8,829 -2.5%
Value US$176,580
2.1
GRAHAM RICHARD A SVP, Development Officer
Transaction date
Sale
Price
19.47
Quantity 7,500 -5.7%
Value US$146,058
2.9
WORBOYS PHILIP D SVP, Research & Transl Science Officer
Transaction date
Sale
Price
18.00
Quantity 4,246 -1.3%
Value US$76,428
2.3
HAUMANN BRETT K Chief Medical Officer Officer
Transaction date
Sale
Price
18.29
Quantity 25,000 -8.1%
Value US$457,240
2.9
WORBOYS PHILIP D SVP, Research & Transl Science Officer
Transaction date
Sale
Price
18.00
Quantity 17,103 -4.9%
Value US$307,854
SABESAN VIJAY SVP, Technical Operations Officer
Transaction date
Sale
Price
21.03
Quantity 1,027 -0.7%
Value US$21,598
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-08 2026-07-07 S Sale
3.2
Samaha Eli
Large shareholder
4,516 -9.9%
126.72
US$2,061,520 		4,516 -9.9% 126.72 US$2,061,520
2026-07-08 2026-07-06 S Sale
3.2
Samaha Eli
Large shareholder
12,359 -48.0%
274.91
US$1,702,475 		12,359 -48.0% 274.91 US$1,702,475
2026-07-01 2026-07-01 S Sale
3.2
Samaha Eli
Large shareholder
55,495 -6.6%
374.00
US$3,943,815 		55,495 -6.6% 374.00 US$3,943,815
2026-07-01 2026-06-30 S Sale
3.2
Samaha Eli
Large shareholder
25,027 -0.3%
17.13
US$428,788 		25,027 -0.3% 17.13 US$428,788
2026-07-01 2026-06-29 S Sale
3.2
Samaha Eli
Large shareholder
273,871 -2.9%
17.23
US$4,720,139 		273,871 -2.9% 17.23 US$4,720,139
2026-06-17 2026-06-15 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
6,657 -2.8%
16.39
US$109,079 		6,657 -2.8% 16.39 US$109,079
2026-06-17 2026-06-15 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
3,328 -1.4%
16.38
US$54,525 		3,328 -1.4% 16.38 US$54,525
2026-06-17 2026-06-15 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
3,329 -1.4%
16.39
US$54,563 		3,329 -1.4% 16.39 US$54,563
2026-06-15 2026-06-15 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
13,314
16.39
US$218,167 		13,314 16.39 US$218,167
2026-03-18 2026-03-16 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
7,766 -3.2%
13.92
US$108,073 		7,766 -3.2% 13.92 US$108,073
2026-03-18 2026-03-16 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
15,534 -6.1%
14.00
US$217,476 		15,534 -6.1% 14.00 US$217,476
2026-03-18 2026-03-16 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
7,767 -2.9%
13.92
US$108,088 		7,767 -2.9% 13.92 US$108,088
2026-03-16 2026-03-16 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
31,067
13.96
US$433,637 		31,067 13.96 US$433,637
2025-12-05 2025-12-03 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
15,534 -5.3%
18.75
US$291,252 		15,534 -5.3% 18.75 US$291,252
2025-12-05 2025-12-03 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
7,766 -2.6%
18.75
US$145,619 		7,766 -2.6% 18.75 US$145,619
2025-12-05 2025-12-03 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
7,767 -2.5%
18.75
US$145,630 		7,767 -2.5% 18.75 US$145,630
2025-12-03 2025-12-03 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
31,067
18.75
US$582,500 		31,067 18.75 US$582,500
2025-12-01 2025-11-26 PlS Planned sale
1.7
BROSHY ERAN
Non-Executive Director
15,501 -25.7%
20.00
US$310,020 		15,501 -25.7% 20.00 US$310,020
2025-12-01 2025-11-26 PlS Planned sale
1.7
BROSHY ERAN
Non-Executive Director
14,000 -18.9%
20.00
US$280,000 		14,000 -18.9% 20.00 US$280,000
2025-11-26 2025-11-26 PrS Proposed sale
1.7
ERAN BROSHY

Director

Non-Executive Director
29,501
20.00
US$590,020 		29,501 20.00 US$590,020
2025-11-13 2025-11-11 PlS Planned sale
1.7
BROSHY ERAN
Non-Executive Director
14,000 -23.3%
18.50
US$259,000 		14,000 -23.3% 18.50 US$259,000
2025-11-13 2025-11-11 PlS Planned sale
1.7
BROSHY ERAN
Non-Executive Director
15,500 -25.1%
17.00
US$263,500 		15,500 -25.1% 17.00 US$263,500
2025-11-13 2025-11-11 PlS Planned sale
1.7
BROSHY ERAN
Non-Executive Director
29,500 -32.3%
18.50
US$545,750 		29,500 -32.3% 18.50 US$545,750
2025-11-12 2025-11-11 PrS Proposed sale
1.7
ERAN BROSHY

Director

Non-Executive Director
45,000
17.98
US$809,250 		45,000 17.98 US$809,250
2025-07-16 2025-07-14 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.2%
11.39
US$45,552 		4,000 -1.2% 11.39 US$45,552
2025-07-16 2025-07-14 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
5,318 -1.6%
11.39
US$60,548 		5,318 -1.6% 11.39 US$60,548
2025-07-16 2025-07-14 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
682 -0.2%
11.39
US$7,770 		682 -0.2% 11.39 US$7,770
2025-07-14 2025-07-14 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
10,000
11.39
US$113,869 		10,000 11.39 US$113,869
2025-06-04 2025-06-02 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
24,000 -6.6%
11.00
US$264,000 		24,000 -6.6% 11.00 US$264,000
2025-06-02 2025-06-02 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
24,000
11.00
US$264,000 		24,000 11.00 US$264,000
2025-04-23 2025-04-21 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.1%
9.00
US$36,000 		4,000 -1.1% 9.00 US$36,000
2025-01-23 2025-01-21 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.3%
9.00
US$36,000 		4,000 -1.3% 9.00 US$36,000
2025-01-21 2025-01-21 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
4,000
9.00
US$36,000 		4,000 9.00 US$36,000
2024-11-13 2024-11-11 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.2%
9.00
US$36,000 		4,000 -1.2% 9.00 US$36,000
2024-08-09 2024-08-07 B Purchase
3.2
Samaha Eli
Large shareholder
999,800 +11.7%
7.80
US$7,798,440 		999,800 +11.7% 7.80 US$7,798,440
2024-07-12 2024-07-10 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.2%
9.00
US$36,000 		4,000 -1.2% 9.00 US$36,000
2024-05-03 2024-05-01 B Purchase
3.2
Samaha Eli
Large shareholder
499,324 +6.2%
8.75
US$4,369,085 		499,324 +6.2% 8.75 US$4,369,085
2024-05-03 2024-05-01 B Purchase
3.2
Samaha Eli
Large shareholder
999,800 +14.3%
8.75
US$8,748,250 		999,800 +14.3% 8.75 US$8,748,250
2024-02-22 2024-02-22 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
1,254 -0.4%
8.71
US$10,922 		1,254 -0.4% 8.71 US$10,922
2023-11-22 2023-11-21 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
1,378 -0.4%
10.29
US$14,180 		1,378 -0.4% 10.29 US$14,180
2023-11-16 2023-11-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,482 -0.7%
10.22
US$25,366 		2,482 -0.7% 10.22 US$25,366
2023-11-14 2023-11-14 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,482
10.22
US$25,366 		2,482 10.22 US$25,366
2023-10-18 2023-10-16 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,482 -0.7%
9.03
US$22,412 		2,482 -0.7% 9.03 US$22,412
2023-10-16 2023-10-16 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,482
9.03
US$22,412 		2,482 9.03 US$22,412
2023-09-18 2023-09-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,482 -0.7%
9.89
US$24,547 		2,482 -0.7% 9.89 US$24,547
2023-09-14 2023-09-14 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,482
9.89
US$24,547 		2,482 9.89 US$24,547
2023-08-24 2023-08-22 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
1,807 -0.5%
9.47
US$17,112 		1,807 -0.5% 9.47 US$17,112
2023-08-15 2023-08-11 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,322 -0.7%
9.99
US$23,197 		2,322 -0.7% 9.99 US$23,197
2023-08-11 2023-08-11 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,322
9.99
US$23,197 		2,322 9.99 US$23,197
2023-07-18 2023-07-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,322 -0.7%
9.84
US$22,848 		2,322 -0.7% 9.84 US$22,848
2023-07-14 2023-07-14 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,322
9.84
US$22,848 		2,322 9.84 US$22,848
2023-06-16 2023-06-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,322 -0.7%
10.69
US$24,822 		2,322 -0.7% 10.69 US$24,822
2023-06-14 2023-06-14 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,322
10.69
US$24,822 		2,322 10.69 US$24,822
2023-06-12 2023-06-08 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
1,790 -0.5%
11.13
US$19,923 		1,790 -0.5% 11.13 US$19,923
2023-06-08 2023-06-08 PrS Proposed sale
2.6
RHONDA FARNUM

Officer

Officer
1,790
11.13
US$19,923 		1,790 11.13 US$19,923
2023-05-17 2023-05-15 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,322 -0.6%
11.26
US$26,146 		2,322 -0.6% 11.26 US$26,146
2023-05-15 2023-05-15 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,322
11.26
US$26,146 		2,322 11.26 US$26,146
2023-04-18 2023-04-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,323 -0.6%
11.88
US$27,597 		2,323 -0.6% 11.88 US$27,597
2023-04-14 2023-04-14 PrS Proposed sale
2.1
RICHARD A GRAHAM

Officer

Officer
2,323
11.88
US$27,597 		2,323 11.88 US$27,597
2023-03-16 2023-03-14 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,323 -0.6%
10.32
US$23,973 		2,323 -0.6% 10.32 US$23,973
2023-03-13 2023-03-09 S Sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
4,000 -1.1%
10.20
US$40,800 		4,000 -1.1% 10.20 US$40,800
2023-03-08 2023-03-06 PlS Planned sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,323 -0.6%
10.05
US$23,346 		2,323 -0.6% 10.05 US$23,346
2022-12-16 2022-12-14 S Sale
3.5
Winningham Rick E

CHIEF EXECUTIVE OFFICER

Executive Director
50,000 -3.6%
11.19
US$559,500 		50,000 -3.6% 11.19 US$559,500
2022-12-05 2022-12-01 S Sale
2.1
GRAHAM RICHARD A

SVP, RESEARCH & DEVELOPMENT

Officer
2,084 -0.7%
10.73
US$22,361 		2,084 -0.7% 10.73 US$22,361
2022-11-22 2022-11-18 S Sale
2.8
Hindman Andrew A.

SVP, CHIEF FINANCIAL OFFICER

Officer
65,000 -13.7%
11.02
US$716,242 		65,000 -13.7% 11.02 US$716,242
2022-08-18 2022-08-16 S Sale
2.1
GRAHAM RICHARD A

SVP, DEVELOPMENT

Officer
4,906 -1.3%
9.71
US$47,640 		4,906 -1.3% 9.71 US$47,640
2022-08-11 2022-08-09 S Sale
2.1
GRAHAM RICHARD A

SVP, DEVELOPMENT

Officer
15,086 -3.9%
8.79
US$132,606 		15,086 -3.9% 8.79 US$132,606
2022-05-24 2022-05-23 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
1,081 -0.3%
8.93
US$9,653 		1,081 -0.3% 8.93 US$9,653
2022-03-02 2022-02-28 PlS Planned sale
2.6
Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRS

Officer
2,356 -0.7%
10.16
US$23,947 		2,356 -0.7% 10.16 US$23,947
2021-03-11 2021-03-09 S Sale
2.9
WORBOYS PHILIP D

SVP, Research & Transl Science

Officer
8,829 -2.5%
20.00
US$176,580 		8,829 -2.5% 20.00 US$176,580
2020-12-16 2020-12-14 S Sale
2.1
GRAHAM RICHARD A

SVP, Development

Officer
7,500 -5.7%
19.47
US$146,058 		7,500 -5.7% 19.47 US$146,058
2020-12-07 2020-12-03 S Sale
2.9
WORBOYS PHILIP D

SVP, Research & Transl Science

Officer
4,246 -1.3%
18.00
US$76,428 		4,246 -1.3% 18.00 US$76,428
2020-08-24 2020-08-21 S Sale
2.3
HAUMANN BRETT K

Chief Medical Officer

Officer
25,000 -8.1%
18.29
US$457,240 		25,000 -8.1% 18.29 US$457,240
2020-08-24 2020-08-20 S Sale
2.9
WORBOYS PHILIP D

SVP, Research & Transl Science

Officer
17,103 -4.9%
18.00
US$307,854 		17,103 -4.9% 18.00 US$307,854
2019-12-16 2019-12-12 S Sale SABESAN VIJAY

SVP, Technical Operations

Officer
1,027 -0.7%
21.03
US$21,598 		1,027 -0.7% 21.03 US$21,598
Explore more

More insider trading research around Theravance Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America